Recent share performance snapshot

Cardinal Health (CAH) stock has slipped about 3% over the past week and is roughly flat over the past month, following a decline of around 13% in the past 3 months.

While the 90 day share price return is down 12.68%, the one year total shareholder return of 26.75% and five year total shareholder return of 271.67% suggest longer term momentum has been strong, even as more recent sentiment has cooled.

If you are comparing Cardinal Health with other opportunities in the sector, this could be a good moment to review healthcare focused AI plays through the 39 healthcare AI stocks

So with Cardinal Health shares cooling in recent months, yet trading at a reported 58% discount to an intrinsic estimate and about 26% below the average analyst target, is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 20.5% Undervalued

Cardinal Health's most followed narrative sets a fair value of $245.27 per share versus the last close of $194.88, framing the current pullback as a discount to long term expectations built into that model.

The company's investments in automation, advanced supply chain technology, and new distribution centers are expected to deliver long-term operational efficiencies and cost savings, supporting improved net margins and free cash flow as healthcare shifts to value-based and outpatient models.

Want to see what is behind that optimism on margins and cash generation? The narrative leans heavily on modest growth, higher profitability, and a richer future earnings multiple. Curious how those ingredients mix to justify a higher fair value.

Result: Fair Value of $245.27 (UNDERVALUED)

However, you still need to watch for tighter regulation and pricing pressure, as well as potential contract losses, which could weigh on margins and earnings expectations.

Another way to look at valuation

The narrative leans on discounted cash flows and analyst targets, but the current P/E of 29.4x tells a different story. It sits above the US Healthcare industry on 23.2x, the peer average on 23.7x, and even the fair ratio of 26.4x. This points to higher valuation risk if sentiment shifts.

Next Steps

Cautious after reading this, or seeing a possible opening, either way, act quickly by reviewing both sides of the story through 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you could miss other opportunities that fit your style, so put a few more ideas on your radar with these screeners.

• Target resilient prospects by scanning 63 resilient stocks with low risk scores, which keeps overall risk scores in focus while you build out your watchlist.
• Hunt for mispriced opportunities through the 46 high quality undervalued stocks, which highlights companies with quality fundamentals at lower prices.
• Spot dependable income candidates using the 11 dividend fortresses, which focuses on higher yielding stocks for a stronger cash return profile.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.